Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

45.48 +1.39 (+3.15%)
Streaming Delayed Price Updated: 3:51 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 906,811
Open 44.56
Bid (Size) 45.46 (6)
Ask (Size) 45.50 (3)
Prev. Close 44.09
Today's Range 44.08 - 45.54
52wk Range 39.97 - 72.83
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Reasons to Like EXAS (and 1 Not So Much)
What a brutal six months it’s been for Exact Sciences. The stock has dropped 37.2% and now trades at $44.10, rattling many shareholders. This may have investors wondering how to approach the... 
Via StockStory
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic
Patients who test positive for circulating tumor DNA with the Oncodetect test during surveillance are 50 times more likely to experience cancer recurrence than those with negative results, the company... 
Via Stocktwits
Topics Government
Exposures Political

Performance

YTD
-20.1%
-20.1%
1 Month
-3.4%
-3.4%
3 Month
-17.0%
-17.0%
6 Month
-35.3%
-35.3%
1 Year
-28.4%
-28.4%

More News

Read More
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
From Exact Sciences Corp.
Via Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
2 Stocks Down 59% and 34% to Buy and Hold
Via The Motley Fool
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
From Exact Sciences Corp.
Via Business Wire
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
Via StockStory
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exact Sciences Schedules First Quarter 2025 Earnings Call
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
From Exact Sciences Corp.
Via Business Wire
The Future of Healthcare: 10 Predictions For The Next Decade
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Via Investor's Business Daily
Topics Government
Exposures Political
2 Small-Cap Stocks on Our Watchlist and 1 to Ignore
Via StockStory
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Stock Under $50 to Target This Week and 2 to Turn Down
Via StockStory
Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts
Via Benzinga
Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
From Exact Sciences Corp.
Via Business Wire
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
Via Stocktwits
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Natera (NTRA) Q4 Earnings: What To Expect
Via StockStory
Exact Sciences to Participate in March Investor Conferences
From Exact Sciences Corp.
Via Business Wire

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 45.48
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 04/24/25 03:51 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 7.82B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.